Cargando…
The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease
Alzheimer’s disease (AD) is a chronic neurodegenerative disease, which is associated with learning and memory impairment in the elderly. Recent studies have found that treating AD in the way of chromatin remodeling via histone acetylation is a promising therapeutic regimen. In a number of recent stu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504819/ https://www.ncbi.nlm.nih.gov/pubmed/28702178 http://dx.doi.org/10.1186/s40035-017-0089-1 |